These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. Landesman KA; Stozek M; Freeman NJ Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341 [TBL] [Abstract][Full Text] [Related]
4. Side effects of statins--prevalence, relevance, consequences. Sinzinger H Wien Klin Wochenschr; 2002 Nov; 114(21-22):887-8. PubMed ID: 12528318 [No Abstract] [Full Text] [Related]
5. [Hepatitis associated with treatment with lovastatin. Presentation of 2 cases]. Bruguera M; Joya P; Rodés J Gastroenterol Hepatol; 1998 Mar; 21(3):127-8. PubMed ID: 9607293 [TBL] [Abstract][Full Text] [Related]
6. Statins and male hypogonadism. Cohen PG J Sex Med; 2011 Jun; 8(6):1826. PubMed ID: 21492398 [No Abstract] [Full Text] [Related]
7. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase]. Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616 [TBL] [Abstract][Full Text] [Related]
8. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Tobert JA Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379 [TBL] [Abstract][Full Text] [Related]
9. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. Pappu AS; Bacon SP; Illingworth DR J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170 [TBL] [Abstract][Full Text] [Related]
10. [Statin-induced Parkinson's-syndrome. Reader's letter on the article by J. Finsterer in "Der Nervenarzt" (2003) 74:115-122]. Müller T Nervenarzt; 2003 Aug; 74(8):726-7. PubMed ID: 12904874 [No Abstract] [Full Text] [Related]
11. Side effects of HMG CoA reductase inhibitors. Ahmad S Heart Dis Stroke; 1993; 2(3):262-3. PubMed ID: 8137036 [No Abstract] [Full Text] [Related]
12. 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agents. Gordon DJ; Rifkind BM Ann Intern Med; 1987 Nov; 107(5):759-61. PubMed ID: 3662286 [No Abstract] [Full Text] [Related]
13. Worsening myopathy associated with ezetimibe in a patient with McArdle disease. Perez-Calvo J; Civeira-Murillo F; Cabello A QJM; 2005 Jun; 98(6):461-2. PubMed ID: 15897216 [No Abstract] [Full Text] [Related]
14. Skin lesions due to treatment with simvastatin (Zocor). Feldmann R; Mainetti C; Saurat JH Dermatology; 1993; 186(4):272. PubMed ID: 8513195 [No Abstract] [Full Text] [Related]
15. [Side effects of HMG-CoA Reductase inhibitors in placebo-controlled trials ]. Kreutzkamp B Med Monatsschr Pharm; 2015 Feb; 38(2):73; discussion 74. PubMed ID: 26376546 [No Abstract] [Full Text] [Related]